Synopsis
Synopsis
0
USDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Ba 21401
2. Ba-21401
3. Ciba 21401 Ba
4. Ciba 21401-ba
5. Ethyl 3,5,6-tri-o-benzyl-d-glucofuranoside
6. Glyvenol
7. Tribenol
8. Tribenoside, (alpha)-isomer
9. Tribenoside, (beta)-isomer
1. 10310-32-4
2. Ethyl 3,5,6-tri-o-benzyl-d-glucofuranoside
3. (3r,4r,5r)-4-(benzyloxy)-5-((r)-1,2-bis(benzyloxy)ethyl)-2-ethoxytetrahydrofuran-3-ol
4. D-glucofuranoside, Ethyl 3,5,6-tris-o-(phenylmethyl)-
5. Tbgf
6. Hemocuron
7. Glyvenol
8. 21401-ba
9. Z7n0y673nu
10. Tribenzoside
11. Glyvenal
12. Tribenosido
13. Tribenosidum
14. Glivenol
15. Dsstox_cid_3697
16. Tribenosidum [inn-latin]
17. Tribenosido [inn-spanish]
18. Unii-z7n0y673nu
19. Tribenoside [usan:inn:ban:jan]
20. Einecs 233-687-2
21. Ba 21401
22. Bg-356
23. Tribenoside [mi]
24. Prestwick3_001019
25. Tribenoside [inn]
26. Tribenoside [jan]
27. Ethyl-3,5,6-tri-o-benzyl-d-glucofuranoside
28. Tribenoside [usan]
29. Tribenoside [mart.]
30. Bspbio_001177
31. Tribenoside [who-dd]
32. Bpbio1_001295
33. Schembl7192326
34. Chembl3301681
35. D-glucofuranoside, Ethyl-3,5,6-tris-o-(phenylmethyl)-
36. Chebi:91780
37. Hms2098k19
38. Hms3715k19
39. Tribenoside [ep Monograph]
40. Ba 2140
41. Ex-a4214
42. Mfcd00801089
43. Akos022185031
44. Ccg-221019
45. Db13227
46. (3r,4r,5r)-5-[(1r)-1,2-bis(phenylmethoxy)ethyl]-2-ethoxy-4-phenylmethoxyoxolan-3-ol
47. Ncgc00179274-01
48. Bs-25775
49. Hy-108249
50. Ab00514005
51. Cs-0027714
52. F20469
53. 310t324
54. A896620
55. Glucofuranoside, Ethyl-3,5,6-tri-o-benzyl-, D-
56. Q533119
57. Sr-01000872695
58. Sr-01000872695-1
59. W-200685
60. Brd-a60294240-001-01-1
61. (3r,4r,5r)-5-[(1r)-1,2-bis(phenylmethoxy)ethyl]-2-ethoxy-4-phenylmethoxy-3-oxolanol
Molecular Weight | 478.6 g/mol |
---|---|
Molecular Formula | C29H34O6 |
XLogP3 | 3.9 |
Hydrogen Bond Donor Count | 1 |
Hydrogen Bond Acceptor Count | 6 |
Rotatable Bond Count | 13 |
Exact Mass | 478.23553880 g/mol |
Monoisotopic Mass | 478.23553880 g/mol |
Topological Polar Surface Area | 66.4 Ų |
Heavy Atom Count | 35 |
Formal Charge | 0 |
Complexity | 555 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 4 |
Undefined Atom Stereocenter Count | 1 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Anti-Inflammatory Agents, Non-Steroidal
Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects. (See all compounds classified as Anti-Inflammatory Agents, Non-Steroidal.)
C - Cardiovascular system
C05 - Vasoprotectives
C05A - Agents for treatment of hemorrhoids and anal fissures for topical use
C05AX - Other agents for treatment of hemorrhoids and anal fissures for topical use
C05AX05 - Tribenoside
C - Cardiovascular system
C05 - Vasoprotectives
C05C - Capillary stabilizing agents
C05CX - Other capillary stabilizing agents
C05CX01 - Tribenoside
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Market Place
ABOUT THIS PAGE
A Tribenoside manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Tribenoside, including repackagers and relabelers. The FDA regulates Tribenoside manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Tribenoside API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Tribenoside manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Tribenoside supplier is an individual or a company that provides Tribenoside active pharmaceutical ingredient (API) or Tribenoside finished formulations upon request. The Tribenoside suppliers may include Tribenoside API manufacturers, exporters, distributors and traders.
click here to find a list of Tribenoside suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Tribenoside Drug Master File in Japan (Tribenoside JDMF) empowers Tribenoside API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Tribenoside JDMF during the approval evaluation for pharmaceutical products. At the time of Tribenoside JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Tribenoside suppliers with JDMF on PharmaCompass.
A Tribenoside CEP of the European Pharmacopoeia monograph is often referred to as a Tribenoside Certificate of Suitability (COS). The purpose of a Tribenoside CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Tribenoside EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Tribenoside to their clients by showing that a Tribenoside CEP has been issued for it. The manufacturer submits a Tribenoside CEP (COS) as part of the market authorization procedure, and it takes on the role of a Tribenoside CEP holder for the record. Additionally, the data presented in the Tribenoside CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Tribenoside DMF.
A Tribenoside CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Tribenoside CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Tribenoside suppliers with CEP (COS) on PharmaCompass.
Tribenoside Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Tribenoside GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Tribenoside GMP manufacturer or Tribenoside GMP API supplier for your needs.
A Tribenoside CoA (Certificate of Analysis) is a formal document that attests to Tribenoside's compliance with Tribenoside specifications and serves as a tool for batch-level quality control.
Tribenoside CoA mostly includes findings from lab analyses of a specific batch. For each Tribenoside CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Tribenoside may be tested according to a variety of international standards, such as European Pharmacopoeia (Tribenoside EP), Tribenoside JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Tribenoside USP).
LOOKING FOR A SUPPLIER?